Therapeutic responses in asthma and COPD. Bronchodilators.
about
Airflow obstruction: is it asthma or is it COPD?Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease.Helping patients attain and maintain asthma control: reviewing the role of the nurse practitioner.Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry.Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPDScreening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation.Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist responseAerosol delivery devices and obstructive airway disease.Formoterol in the management of chronic obstructive pulmonary disease.A meta-analysis on the efficacy of oral theophylline in patients with stable COPD.Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?Pharmacotherapy of critical asthma syndrome: current and emerging therapies.The acute management of asthma.The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease.[Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease].Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases.Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor.Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists.
P2860
Q28067052-09E8FD23-3DB4-4090-8601-B40F13D9D50DQ34374230-56B4CD13-352C-40CD-A82E-CF0FA5DBF94CQ34521884-222E53CB-F20B-4114-B5E5-5F95FF274D13Q34571675-1FADBE1B-FCA7-43DB-A932-4B1F84DD6F26Q35135970-7B7B4F4A-41E0-4EF5-9BFF-9604C63B8EE3Q35163697-8F33453C-77C5-4399-B085-2D80CC880F1CQ35201848-56AD0281-AC54-4EE2-9778-6274EA3807C7Q35747040-B7AAE1B0-DC6B-40D6-85E6-1701EE1FB35AQ35960314-0020AD63-0C8D-4201-AB3F-804C43DA712FQ36232072-C959229F-EC49-4E1D-89D7-A37A6DBA569CQ36315050-AEB3BC2C-BF06-44ED-99E7-0C3C8FA38E46Q37070307-3108826A-3C56-48CD-A1B5-56F59EA65709Q37253868-89017D8B-8693-426F-94BA-8A4608154DCCQ37400972-2E3D04E1-1545-4AE6-B1BD-B70E25FE1838Q37804908-04CC73AB-ED47-4150-9DC1-E33FF9041DD6Q38095558-561BFDE5-FD8C-4EF4-917C-28F0C681AFCCQ38157770-C0B94557-DFF6-4281-839D-88637A48871FQ38248502-6240E47E-6970-4AAB-A731-30D72340A188Q38592062-3D69F79E-7BED-40C0-B01F-4F2313BBFC7FQ39317209-4FD2B311-1D3C-43EA-B52A-516968A34F01Q39373760-577D9326-2651-4104-985F-9E812DC374BFQ40829135-2695F698-55EE-4418-80A2-AB205BE8C09CQ41673144-B9B40AC9-B145-4172-9E0E-B9F71D7BF7CDQ42144426-8B2528B3-2C1C-4EEF-A2A0-ADC26079526CQ43849764-065EAA86-C122-4579-8D86-89A3CB2CA4D5Q46174572-D88D99B3-B9A3-400C-AF0A-7D9A46287570Q54196591-57D0AD12-EDFC-4B54-BDFD-FAA215FD35AB
P2860
Therapeutic responses in asthma and COPD. Bronchodilators.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Therapeutic responses in asthma and COPD. Bronchodilators.
@ast
Therapeutic responses in asthma and COPD. Bronchodilators.
@en
type
label
Therapeutic responses in asthma and COPD. Bronchodilators.
@ast
Therapeutic responses in asthma and COPD. Bronchodilators.
@en
prefLabel
Therapeutic responses in asthma and COPD. Bronchodilators.
@ast
Therapeutic responses in asthma and COPD. Bronchodilators.
@en
P1433
P1476
Therapeutic responses in asthma and COPD. Bronchodilators.
@en
P2093
James F Donohue
P304
125S-137S; discussion 159S-161S
P356
10.1378/CHEST.126.2_SUPPL_1.125S
P407
P433
P577
2004-08-01T00:00:00Z